1-3 of 3
Timothy J. Robinson
Close
Sort by
Journal Articles

Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning Results in Favorable Outcomes with Haploidentical Donor Peripheral Blood Stem Cell Transplant

Hany Elmariah, Jongphil Kim, Asmita Mishra, Rawan Faramand, Lia Perez, Aleksandr Lazaryan, Farhad Khimani, Hien Liu, Jose L. Ochoa-Bayona, Michael Nieder, Nicholas Figura, Timothy J Robinson, Taiga Nishihori, Claudio Anasetti, Joseph A. Pidala, Nelli Bejanyan
Journal: Blood
Blood (2023) 142 (Supplement 1): 4900.
https://doi.org/10.1182/blood-2023-187473
Published: 2023
Journal Articles

CD19 Intron Retention Is Mechanism of CAR-T Treatment Resistance in Non-Hodgkin Lymphoma

Jerald Noble, Frederick L. Locke, Constanza Savid-Frontera, Michael D. Jain, Joel G. Turner, Julieta Abraham Miranda, Thushara W Madanayake, Samira Naderinezhad, Salvatore Corallo, Meghan Menges, Kayla Reid, Timothy J Robinson
Journal: Blood
Blood (2023) 142 (Supplement 1): 3506.
https://doi.org/10.1182/blood-2023-185074
Published: 2023
Journal Articles

Multi-Institutional Review of Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphomas

Nikhil Yegya-Raman, Christopher M. Wright, Nicholas B. Figura, Siqi Zhang, Jessica J. Chew, Skyler E. Burke, Austin J. Sim, Michael J. LaRiviere, Jonathan A. Baron, Sumi Sinha, Joanna C. Yang, Timothy J. Robinson, Michael D. Jain, Amit Maity, Ima Paydar, Yolanda D. Tseng, Steve E. Braunstein, Stephen J. Schuster, Elise A. Chong, John P. Plastaras
Journal: Blood
Blood (2022) 140 (Supplement 1): 10900–10901.
https://doi.org/10.1182/blood-2022-157540
Published: 2022